Skip to main content
. Author manuscript; available in PMC: 2015 May 27.
Published in final edited form as: J Neuroimmune Pharmacol. 2015 Jan 9;10(1):102–110. doi: 10.1007/s11481-014-9577-6

Table 1.

Characteristics of study subjects

Category Control (N = 20) HCV (N = 20) Heroin (N = 20) HCV + Heroin (N = 20)
Age (Yrs mean ± SD) 43±4 43±5 40±7 43±6
Range of age (Yrs) 35–46 31–56 29–60 27–53
Gender (male/female) 20/0 20/0 20/0 20/0
Race (ethnic group) Asian (Han) Asian (Han) Asian (Han) Asian (Han)
Heroin use * * +** +**
HCV + +
HIV
*

No history of opiate and other substance abuse

**

Heroin only